Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 9 clinical trials
None
A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants

liver solid organ transplant (SOT) and in healthy adult participants. The primary goal of the study is to evaluate the safety of mRNA-1273 and the serum antibody (Ab) responses obtained 28 days after

Accepts healthy volunteers
  • 0 views
  • 03 Nov, 2021
  • 2 locations
None
Assess the Safety and Immunogenicity of One or Two Doses of Sing2016 M2SR H3N2 Influenza Vaccine

This is a Phase 1b, randomized, double-blind, dose-escalating, age de-escalating, placebo-controlled study of a targeted 220 children, ages 6 months to 17 years, inclusive. This clinical trial is designed to assess the safety and immunogenicity of of one and two doses of Sing2016 M2SR H3N2 influenza vaccine (manufactured by FluGen) …

Accepts healthy volunteers
  • 0 views
  • 01 Dec, 2021
  • 4 locations
None
Efficacy of Systemic Glucocorticoid in the Treatment of Wheezing in Children

We can not predict which wheezing child younger than 3 years of age benefits from systemic glucocorticoid and which one does not. It is not known whether the differences in the efficacy are related to the differences in viral etiology, atopy, immunogical maturity or age of the patient. The study …

prednisolone
atopy
  • 0 views
  • 07 Nov, 2020
  • 1 location
None
Study on Sequential Immunization of Inactivated COVID-19 Vaccine and Recombinant COVID-19 Vaccine (Ad5 Vector) in Elderly Adults

months after vaccination will be observed. In addition, blood samples will be collected on day 0 before the boosting with ad5 vectored vaccine and on day 14, 28 and month 6 after the boosting. Serum

Accepts healthy volunteers
  • 0 views
  • 07 Oct, 2021
  • 1 location
None
Influenza Challenge Study to Determine the Optimal Infection Dose and Safety of a Recombinant H3N2 (A/Texas/71/2017 (H3N2 Clade 3C3a) Influenza Strain

An open-label, dose-ranging influenza challenge study in healthy adult volunteers to determine the optimal infection dose and safety of a recombinant H3N2 (A/Texas/ A/Texas/71/2017 (H3N2, clade 3C3a) influenza strain. The goal of this study is to find a challenge virus dose that is safe and can achieve a symptomatic influenza …

Accepts healthy volunteers
oophorectomy
oseltamivir
peramivir
hysterectomy
  • 0 views
  • 04 Nov, 2021
  • 2 locations
None
Immunogenicity and Safety of COVID-19 Vaccine in Cancer Patients

Serum antibody titre against COVID-19 spike protein will be measured before, after the first dose, and after the second dose (when applicable) in cancer patients who are receiving or received

primary cancer
  • 0 views
  • 12 Jun, 2021
  • 1 location
None
Immune Response to Seasonal Influenza Vaccination in Multiple Sclerosis Patients Receiving Cladribine

with basic immunomodulatory treatment. Serum antibody titers against the respective pathogen will be assessed prior to and 6 to 8 months following vaccination.

  • 0 views
  • 30 Aug, 2021
  • 1 location
None
COVID-19 Antibody Levels After Vaccines

This study will measure the levels of nasal mucosal Immunoglobulin A (IgA) and blood serum IgA up to one year after COVID vaccination, as well as examining what factors might affect antibody levels in the nose. This will be done through nasal epithelial lining fluid collection and standard venipuncture.

  • 0 views
  • 08 Aug, 2021
  • 1 location
None
PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort

DESIGN Longitudinal prospective observational multicentre study. Primary objective: Understand the immune mechanisms driving COVID-19 disease in patients with a history of lung disease

asthma
pulmonary disease
blood test
covid-19
COPD
  • 35 views
  • 31 Aug, 2021
  • 1 location